인벤티지랩 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 진세호, was filed 29 Jun 2026.
인벤티지랩: what insiders have been doing
인벤티지랩, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). From 2 November 2025 to 2 November 2026, the disclosure feed for 인벤티지랩 logged 23 filings by 13 insiders.
Purchases and sales both appear in the filings: 10 purchases (9 insiders, €97k) and 13 sales (7 insiders, €22.0M). The amount is not disclosed for 17 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The largest single trade was a sale of €20.8M by 김주희, published on 2 April 2026, equal to 8.5% of the market capitalisation. The buyers include 7 board members, 1 major shareholder and 1 senior executive.
With 23 filings in twelve months, the company is more active than the median of 7 filings across the 2,655 companies we follow on the same exchange. The full history, which starts in 2022, counts 39 purchases against 17 sales.
In all, 3 purchases were made within 30 days of a purchase by another insider of the company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The last purchase on record was published on 29 June 2026, which is 134 days ago. The median gap between a trade and its publication by DART (FSS) is 7 days. Until a filing is published, the market cannot know about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySale+7 other insiders
Since the insiders bought
- -60.3%Entry ₩55,600 · Close 30 Oct 2026 ₩22,100
- -60.3%Entry ₩55,600 · Close 30 Oct 2026 ₩22,100
- -60.3%Entry ₩55,600 · Close 30 Oct 2026 ₩22,100
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 1,000 sharesShareKRXDART:20260629000348Canonical exit: 27 Sept 2026 (T+90)
- 2,090 sharesShareKRXDART:20260616000056Canonical exit: 14 Sept 2026 (T+90)
- 2,090 sharesKRXDART:20260608000222Canonical exit: 6 Sept 2026 (T+90)
- 5,000 sharesShareKRXDART:20260605000566
- 5,000 shares@ ₩9,667.000.012% mcap100.0% of flowShareKRXDART:20260508000881Canonical exit: 4 Aug 2026 (T+90)
- 10,000 shares@ ₩9,667.000.023% mcap100.0% of flowShareKRXDART:20260508000897Canonical exit: 4 Aug 2026 (T+90)
- 4,000 shares@ ₩10,000.000.0048% mcap100.0% of flowShareKRXDART:20260508000867Canonical exit: 4 Aug 2026 (T+90)
- 13,642 shares0.19% mcap2.2% of flowKRXDART:20260413002979
- 20,298 shares@ ₩65,390.000.31% mcap100.0% of flowShareKRXDART:20260413003111
- 6,656 sharesShareKRXDART:20260407002558Canonical exit: 30 Jun 2026 (T+90)
- 570,125 shares8.50% mcap97.8% of flowKRXDART:20260402000984
- 50,600 sharesKRXDART:20260206002078
- 29,400 sharesShareKRXDART:20260204000540Canonical exit: 5 May 2026 (T+90)
- Other0DART
- 20,000 sharesShareKRXDART:20260204000535
- 3,600 sharesShareKRXDART:20260204000575Canonical exit: 5 May 2026 (T+90)
- 117,874 sharesKRXDART:20260107000527
- 20,000 sharesShareKRXDART:20251216000424Canonical exit: 16 Mar 2026 (T+90)
- 56,000 sharesKRXDART:20251201000794
- 15,000 sharesShareKRXDART:20251201000798
- 25,000 sharesShareKRXDART:20251201000792
- 5,215 sharesShareKRXDART:20251201000797
- 8,000 sharesShareKRXDART:20251201000795
- 8,000 sharesShareKRXDART:20251201000778
- 10,000 sharesShareKRXDART:20250808000266Canonical exit: 6 Nov 2025 (T+90)
25 of 75 declarations
About 인벤티지랩
InvenTige Lab is a company in the health and pharmaceutical sector, listed on the XKRX. It focuses on developing innovative solutions to enhance healthcare.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
